Ergoteles LLC Curis Inc Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $23,181 - $849,324	-49,322 Reduced 39.68%	74,979 $41,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $350,611 - $7.11 Million	-473,799 Reduced 79.22%	124,301 $87,000
Q2 2022 Aug 12, 2022	BUY	$0.71 - $2.43 $424,651 - $1.45 Million	598,100 New	598,100 $589,000
Q2 2021 Aug 12, 2021	SELL	$7.45 - $16.27 $86,047 - $187,918	-11,550 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$8.78 - $12.8 $101,408 - $147,840	11,550 New	11,550 $131,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.